How does Cardiff Oncology, Inc. (CRDF)'s PE ratio compare to its industry?

Cardiff Oncology, Inc. (CRDF) trades at a PE of 0.0 versus a Biotechnology Industry median of 21.3 (604 companies). A relative PE gap is one signal, not investment advice — see the full DCF fair value at evidinvest.com/valuation/CRDF.

CRDF PE Benchmarks

Cardiff Oncology, Inc. • Healthcare

PE Type:

Period:

Data Quality:Good

Current PE Ratio

N/A

Diluted • annual

Forward PE

N/A

NTM Estimate

Sector Companies

500

314 with PE data

Sector Median PE

79.4

314 companies

Peer Companies

7

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

314

Median PE

79.4

PE Range

3.1 - 198.9

Forward PE Median

21.1

Healthcare Sector

2917 companies • sector

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:22.3

Average PE:35.3

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.9 - 43.8

Biotechnology Industry

604 companies • industry

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:21.3

Average PE:35.7

Min PE:0.1

Max PE:198.1

25th-75th %ile:6.2 - 48.0

Peer Companies

3 companies • peers

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:35.9

Average PE:40.8

Min PE:16.6

Max PE:70.0

25th-75th %ile:26.3 - 53.0

Peer Companies

(7 companies)

GNPX

RVPH

GLSI

CGTX

PDSB

LPTX

CRVS

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 8/19/2026, 4:45:48 PM• Based on latest annual diluted PE ratios

CRDF PE Benchmarks

Cardiff Oncology, Inc. • Healthcare

PE Type:

Period:

Data Quality:Good

Current PE Ratio

N/A

Diluted • annual

Forward PE

N/A

NTM Estimate

Sector Companies

500

314 with PE data

Sector Median PE

79.4

314 companies

Peer Companies

7

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

314

Median PE

79.4

PE Range

3.1 - 198.9

Forward PE Median

21.1

Healthcare Sector

2917 companies • sector

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:22.3

Average PE:35.3

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.9 - 43.8

Biotechnology Industry

604 companies • industry

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:21.3

Average PE:35.7

Min PE:0.1

Max PE:198.1

25th-75th %ile:6.2 - 48.0

Peer Companies

3 companies • peers

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:35.9

Average PE:40.8

Min PE:16.6

Max PE:70.0

25th-75th %ile:26.3 - 53.0

Peer Companies

(7 companies)

GNPX

RVPH

GLSI

CGTX

PDSB

LPTX

CRVS

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 8/19/2026, 4:45:48 PM• Based on latest annual diluted PE ratios

CRDF PE Benchmarks

Sector Analysis: Healthcare

Healthcare Sector

Biotechnology Industry

Peer Companies

Peer Companies

Stock List PE Comparison

More on CRDF

Compare with peers

Explore

CRDF PE Benchmarks

Sector Analysis: Healthcare

Healthcare Sector

Biotechnology Industry

Peer Companies

Peer Companies

Stock List PE Comparison

More on CRDF

Compare with peers

Explore